Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T15:06:29.788Z.
Calculation as of: 2026-10-06T15:06:29.788Z.
Quote observation: 2026-10-06T15:05:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d443e069440aa0ac5a32f25afa0d38c48efe58a411ec60778b8439bb1c5cf92a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Eledon Pharmaceuticals, Inc.
Market Cap
$192.97M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$204.17M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$183.14M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$183.55M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$180.82M
EV/EBITDA Ratio
143.20x
TTM Avg
155.63x
3Y Avg
70.41x
5Y Avg
70.41x
Market Cap
$178.11M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $192.97M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $189.45M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $204.17M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $183.14M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.55M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $180.82M | 143.20x | 155.63x | 70.41x | 70.41x |
| Compass Therapeutics, Inc. (CMPX)vs › | $178.11M | N/A | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $209.91M | N/A | 16.55x | 16.55x | 16.55x |
| Cue Biopharma, Inc. (CUE)vs › | $175.73M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $172.90M | N/A | 7.02x | 7.02x | 7.02x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
